Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BBIO
BBIO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BBIO News
Acoramidis Shows Significant Long-Term Benefits in Heart Failure Treatment
8h ago
Newsfilter
BridgeBio Submits NDA for BBP-418 to Treat LGMD2I/R9
16h ago
Newsfilter
BridgeBio Pharma (BBIO.US) Director Plans to Sell $9.52 Million in Common Stock via Form 144
Mar 13 2026
moomoo
BridgeBio Presents Positive Interim Data for BBP-418 in LGMD2I/R9
Mar 11 2026
Yahoo Finance
BridgeBio Pharma Stock Soars on Price Target Upgrade
Mar 11 2026
Yahoo Finance
U.S. Markets Closed with Mixed Results on Tuesday, Driven by BridgeBio Pharma's Gains and Centene's Declines
Mar 10 2026
Barron's
BridgeBio's Promising Biotech Pipeline Highlighted by William Blair
Mar 10 2026
Benzinga
BridgeBio Presents Interim Data for BBP-418 at MDA Conference
Mar 05 2026
NASDAQ.COM
BridgeBio Pharma Q4 2025 Earnings Call Insights
Feb 25 2026
seekingalpha
BridgeBio (BBIO) Q4 2025 Earnings Call Transcript
Feb 25 2026
NASDAQ.COM
BridgeBio Pharma Q4 Earnings Beat Expectations with Strong Revenue Growth
Feb 24 2026
seekingalpha
BridgeBio Pharma to Announce Q4 Earnings on February 24
Feb 23 2026
seekingalpha
BridgeBio Pharma to Participate in Multiple Healthcare Investor Conferences
Feb 23 2026
Newsfilter
Worst Performing Large-Cap Stocks Last Week
Feb 22 2026
Benzinga
Cormorant Increases MoonLake Stake Above 6%
Feb 18 2026
stocktwits
BridgeBio Pharma Approves Employee Equity Grants
Feb 17 2026
Newsfilter
Show More News
